INVO Fertility (IVF) Free Cash Flow Growth (5y) (2016 - 2026)
INVO Fertility (IVF) Free Cash Flow Growth (5y) (2016 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.36 Bn | 175.06 Bn | 6.27 Bn |
| 2 | Stryker | 128.86 Bn | 125.99 Bn | 3.81 Bn |
| 3 | Medtronic | 108.02 Bn | 98.80 Bn | 6.41 Bn |
| 4 | Boston Scientific | 68.21 Bn | 66.76 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 48.19 Bn | 44.52 Bn | 1.29 Bn |
| 6 | Dexcom | 28.30 Bn | 27.18 Bn | 750.30 Mn |
| 7 | GE HealthCare Technologies | 28.02 Bn | 25.74 Bn | 1.98 Bn |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - |
| 9 | Koninklijke Philips | 24.11 Bn | 20.99 Bn | 2.07 Bn |
| 10 | INVO Fertility | 1.51 Mn | -3.40 Mn | 732,978.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -2.01% |
| Sep 30, 2025 | -13.20% |
| Jun 30, 2025 | -8.91% |
| Mar 31, 2025 | -32.13% |
| Dec 31, 2024 | 2.02% |
| Sep 30, 2024 | -2.42% |
| Jun 30, 2024 | -30.82% |
| Mar 31, 2024 | -16.02% |
| Dec 31, 2023 | -20.91% |
| Sep 30, 2023 | -63.18% |
| Jun 30, 2023 | -50.62% |
| Mar 31, 2023 | -98.41% |
| Dec 31, 2022 | -119.97% |
| Sep 30, 2022 | -126.91% |
| Jun 30, 2022 | -144.25% |
| Mar 31, 2022 | -79.20% |
| Dec 31, 2021 | -61.94% |
| Sep 30, 2021 | -95.05% |
| Jun 30, 2021 | -63.74% |
| Mar 31, 2021 | -90.77% |